Longaeva Partners »

Ptc Therapeutics I shares owned by Longaeva Partners

Quarter-by-quarter ownership of Ptc Therapeutics I (PTCT) shares owned by Longaeva Partners from 13F filings

Historical chart of Longaeva Partners investment in Ptc Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Ptc Therapeutics I held by Longaeva Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ptc Therapeutics I by Longaeva Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $9.1M 112k 81.57

More positions owned by Longaeva Partners

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Goldman Sachs Put Option (GS)
JPMorgan Chase & Co. (JPM)
Select Sector Spdr Tr St Str Care Etf Call Option (XLV)
Bank of America Corporation (BAC)
Pfizer Call Option (PFE)
Boston Scientific Corporation Call Option (BSX)
Fifth Third Ban (FITB)
Huntington Bancshares Incorporated (HBAN)
Moody's Corporation (MCO)
Mettler-Toledo International (MTD)
Lpl Financial Holdings (LPLA)
Us Bancorp Com New (USB)
Morgan Stanley Com New (MS)

View all positions for Longaeva Partners

Top funds holding Ptc Therapeutics I

BlackRock
Rtw Investments
Jupiter Topco
Henderson Group
Vanguard Portfolio Management
State Street Corporation
Wellington Management Company
Vanguard Capital Management
Geode Capital Management
Toronto-Dominion Bank
Westfield Capital Management Company
Hood River Capital Management
Armistice Capital
William Blair Investment Management
D. E. Shaw & Co

View all funds holding Ptc Therapeutics I